Dr.Nader Javadi (USA)
Hematology / Oncology

Dr. Nader Javadi, M.D. is a board certified Hematologist and Oncologist with more than 15 years of experience. He’s a graduate of Internal medicine residency at Cleveland Clinic and completed his fellowship in Hematology/Oncology program at St. Louis University hospital. He’s the founder and current director of Hope Health Center at Reseda, California. Dr. Javadi has been a Clinical Assistant professor at University of California – Irvine between 2004-2007. During the last 15 years he has been involved in many clinical trials in the field of oncology and been a thought leader in specific areas like prostate, liver, ovarian, colon and lung cancers. He has been the chairman of the cancer committee at Riverside Cancer Foundation between 2004-2007 (Riverside, California). Dr. Javadi has been featured as an oncology expert in many national and international TV and radio stations including NBC news and multiple Persian and Armenian TV/radio stations.

At Hope Health Center (HHC) cancer patients are treated in a completely different way compared to standard approach which is practiced elsewhere. At Hope Health Center, Dr. Javadi has created a special treatment protocol for each cancer patient called “Precision Cancer Medicine”. By using this method a specific, customized therapy is given to each individual based on his/her own tumor genetics.

The technology used is called “The Next Generation Gene Sequencing” which analyzes more than 100 cancer related genes in a tumor sample. Knowing which mutations are present in each tumor can help Dr. Javadi tailor a patient’s treatment to the unique genetic features present in his/her cancer cells. For example, a patient could be given a standard chemotherapy and expect a maximum 35 percent response rate/shrinkage of tumor. But if we know that patient has a specific mutation, he/she can be offered.

Dr Javadi has received awards from Who's Who 2017, American Health Council 2018， National Profile Plus 2018， Top 100 Registry 2020， etc.

Dr.Yong Gao (China)
Oncology

Prof Gao a doctoral supervisor at Tongji University in Shanghai and Nanjing Medical University. He has been engaged in clinical diagnosis and treatment of tumors for more than 30 years, and is good at multi-disciplinary diagnosis and treatment of gastric cancer, intestinal cancer, lung cancer and breast cancer, as well as tumor cell immunotherapy, and liver metastasis. He is keen on tumor target detection, analysis, target interpretation and therapy.

He was as a visiting associate professor at MD Anderson Cancer Center in the United States from 2007 to 2009. He is now a member of CSCO Pancreatic Cancer Professional Committee of the Chinese Society of Clinical Oncology, a senior member of ASCO of the American Society of Clinical Oncology, a member of Shanghai Medical Association Cancer Society, of the Palliative Treatment Professional Committee of the Chinese Medical Association, and of Shanghai Medical Association Cancer Society.

He has led national level projects, published research papers in internationally renowned journals such as Cancer Research, Gastroenterology, Clinical Cancer Research, as well as dozens of papers in domestic core journals. His oncology department was awarded the Key Specialty Unit in Shanghai in 2012.